Simpson Thacher Represents Centerbridge Partners in Connection with its Investment in Remedi SeniorCare
09.01.11
This is only gets display when printing
Simpson Thacher represented Centerbridge Partners in the acquisition by one of its affiliates of a controlling interest in Remedi SeniorCare Holding Corporation for an aggregate capital commitment of up to $300 million. The investment will be used to support the continued development and deployment of Remedi’s automated medication administration technology, as well as acquisitions and greenfield start-up pharmacies in new markets across the United States.
Remedi SeniorCare, based in Baltimore, is one of the nation’s largest institutional pharmacy companies. Through its patented technologies and web-based solutions, Remedi SeniorCare enables long-term care facility operators and providers to deliver medication management and other services in skilled nursing and assisted living facilities.
The Simpson Thacher team includes: Caroline Gottschalk, Daniel Tseng and Gibbs Fryer (M&A); Greg Grogan and Craig Katerberg (Executive Compensation and Employee Benefits); Gary Mandel, Jonathan Goldstein and Danny Salinas (Tax); Jonathan Karen and Nicole Washington (Private Funds); Marissa Wesely (Credit); Lori Lesser and Jodie Sopher Pimentel (Intellectual Property); Adeeb Fadil (Environmental); and Joseph Tringali and Michael Naughton (Antitrust).